Startup database

Oncology

Detection, sequencing, treatment selection and survivorship, the vertical where precision medicine has moved furthest into routine care.

36 companies

Grail

Early cancer detection

Creates multi-cancer early detection blood tests to identify cancer before symptoms appear.

Public$2B raisedMenlo Park, United States

Caris Life Sciences

Cancer screening and diagnostics

Offers molecular profiling services to identify precise therapeutic options for cancer patients.

Growth$1.7B raisedIrving, United States

Tempus

Precision medicine platform

Signal 100

Provides data and AI-driven precision medicine solutions for oncology clinics and researchers.

Public$1.4B raisedChicago, United States

Freenome

Early cancer detection

Develops blood tests for early cancer detection using genomics and machine learning.

Series C+$1.4B raisedSouth San Francisco, United States

Guardant Health

Early cancer detection

Liquid biopsy company whose Guardant360 CDx panel is the companion diagnostic for Lilly's Inluriyo combination.

Public$550M raisedRedwood City, United States

Delfi Diagnostics

Cancer screening and diagnostics

Develops liquid biopsy tests using fragmentomics to detect lung and other cancers early.

Series C+$335M raisedBaltimore, United States

Owkin

AI drug discovery

Applies federated learning and AI to biological data for drug discovery and diagnostics.

Series C+$304M raisedParis, France

ConcertAI

Real-world data and analytics

Provides real-world data and AI software solutions for oncology clinical development.

Growth$300M raisedCambridge, United States

Thyme Care

Oncology care navigation

Signal 100

Provides oncology care navigation and support to improve patient outcomes and lower costs.

Series C+$300M raisedNashville, United States

BostonGene

Cancer screening and diagnostics

Performs integrated genomic and transcriptomic profiling of patient tumors and microenvironments.

Series B$250M raisedBoston, United States

Sophia Genetics

Precision medicine platform

Standardizes clinical genomic data using AI to support precision oncology worldwide.

Public$250M raisedSaint-Sulpice, Switzerland

Paige

AI digital pathology

Signal 100

Creates AI-native digital pathology software to assist pathologists in diagnosing cancer.

Series C+$220M raisedNew York, United States

Epic Sciences

Cancer screening and diagnostics

Analyses circulating tumor cells to provide actionable data for personalized cancer therapies.

Series C+$200M raisedSan Diego, United States

Mirxes

Cancer screening and diagnostics

Develops microRNA liquid biopsy tests for the early detection of gastric and other cancers.

Series C+$177M raisedSingapore

Geneoscopy

Cancer screening and diagnostics

Develops non-invasive, stool-based RNA tests to detect colorectal cancer and precancerous lesions.

Series C+$115M raisedSt. Louis, United States

COTA

Real-world data and analytics

Translates complex clinical data into real-world evidence to improve oncology patient care.

Series C+$111M raisedBoston, United States

ArteraAI

Precision medicine platform

Signal 100

Develops AI prognostic tests to personalize cancer treatment plans and improve outcomes.

Series B$110M raisedSan Francisco, United States

Ibex Medical Analytics

AI-powered pathology diagnostics

Applies artificial intelligence to cancer diagnostics in digital pathology workflows.

Series C+$102M raisedTel Aviv, Israel

Link Cell Therapies

Logic-gated CAR-T

Cell therapy company building logic-gated CAR-T treatments for solid tumors.

Series A$90M raisedSouth San Francisco, California, USA

TwoStep Therapeutics

Peptide-drug conjugates

Multi-specific peptide-drug conjugates that target several tumor integrins at once.

Series A$71.2M raisedSan Carlos, United States

Karkinos Healthcare

Oncology care platform

Builds a distributed oncology network to improve cancer care delivery across India.

Series B$45M raisedMumbai, India

ImpriMed

Functional precision medicine

Live-cell testing and multimodal AI for precision oncology and drug-development decisions.

Series A$33M raisedPalo Alto, CA, USA

Lucence

Cancer screening and diagnostics

Develops ultra-sensitive liquid biopsy tests for multi-cancer early detection and profiling.

Series B$29M raisedSingapore

Jasper Health

Oncology care navigation

Offers a digital coaching and care coordination platform for cancer patients and caregivers.

Series A$27M raisedBoise, United States

Massive Bio

Clinical trial matching

Uses AI to match cancer patients with clinical trials globally, expanding access.

Series B$23M raisedNew York, United States

CancerIQ

Cancer risk assessment

Helps clinicians identify, track, and manage patients with high genetic risk of cancer.

Series B$22M raisedChicago, United States

Kheiron Medical Technologies

AI-powered radiology diagnostics

Deploys deep learning to assist radiologists in detecting early-stage breast cancer.

Series A$22M raisedLondon, United Kingdom

Belong.Life

Patient companion software

Creates personalized social networks and navigational apps for cancer patients and caregivers.

Series B$19M raisedTel Aviv, Israel

Mika Health

Patient companion software

Offers a digital therapeutic application designed to support cancer patients during therapy.

Series B$15M raisedBerlin, Germany

Outcomes4Me

Patient empowerment platform

Empowers cancer patients with personalized treatment navigation, symptom tracking, and clinical trials.

Series A$12M raisedBoston, United States

Vara

AI-powered radiology diagnostics

Operates an AI-driven mammography platform to make breast cancer screening globally accessible.

Series A$11M raisedBerlin, Germany

SkinVision

Cancer screening

Develops a regulated smartphone application for early detection and monitoring of skin cancer.

Series B$10M raisedAmsterdam, Netherlands

I3LUNG

Multimodal AI decision support

A European research consortium building explainable AI decision support for metastatic lung cancer.

GrowthUndisclosedMilan, Italy

OncoHealth

Oncology benefit management

Provides digital health solutions and oncology utilization management software for health insurers.

GrowthUndisclosedAtlanta, United States

SimBioSys

Precision oncology

Precision oncology software for breast cancer recurrence prognosis and MRI visualization.

Undisclosed

Telix Pharmaceuticals

Radiopharmaceuticals and theranostics

A commercial-stage biopharmaceutical company focused on diagnostic and therapeutic radiopharmaceuticals.

PublicUndisclosedMelbourne, Australia